Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
School of Medicine, Tsinghua University, Beijing, 100084, China.
Int Orthop. 2024 Jan;48(1):49-56. doi: 10.1007/s00264-023-05944-1. Epub 2023 Aug 26.
The reduction of hip and knee arthroplasty surgical volume has been reported in many countries during the COVID-19 pandemic. In China, there is no national joint registry system and the impact of COVID-19 towards surgical volume remains unclear. The aim of this study was to investigate the hip and knee arthroplasty surgical volume in China during the pandemic and evaluate its change trends.
Annual sale numbers of prostheses used in total knee arthroplasty (TKA), total hip arthroplasty (THA), and femoral head replacement (FHR) from 2011 to 2021 was collected from providers registered in National Medical Products Administration (NMPA). Annual surgical volume of TKA, THA, FHR, unicompartmental knee arthroplasty (UKA), and revision of hip/knee arthroplasty (RJA) was collected from member hospitals of Beijing Joint Society (BJS). We used linear regression to estimate the loss of surgical volume. Annual surgical volume obtained from Britain and Australian joint registries were used to make comparison.
In China, the surgical volume of THA/FHR, TKA, and UKA in 2020 all decreased compared to the predicted value, with a reduction of 82,525 cases (13.46%), 165,178 cases (33.50%), and 151 cases (0.65%), respectively. All the three procedures showed significant recovery in 2021. The surgical volumes of THA/FHR and UKA were 68,813 and 9402 cases higher than predicted levels, respectively, while TKA volume remained slightly below the predicted level. The regional statistics in Beijing showed similar change mode. In 2020, the surgical volume of THA/FHR, TKA, FHR, and UKA all decreased compared to the predicted value, with a reduction of 5031 cases (43.37%), 5290 cases (40.69%), 620 cases (29.18%), and 925 cases (39.11%), respectively. In 2021, with the exception of FHR, the number of these procedures increased compared to 2020, but remained below the predicted value. Compared with the data from Britain and Australia, China experienced less reduction and faster recovery in the proportions of elderly people (> 65 years old) who undergo hip and knee arthroplasty during the COVID-19 pandemic.
During the COVID-19 pandemic, although hip and knee arthroplasty surgical volume in China showed a similar "restoration-recovery" change pattern with other countries, China took fewer losses in this field.
在 COVID-19 大流行期间,许多国家报告髋关节和膝关节置换手术量减少。在中国,没有全国性的关节登记系统,COVID-19 对手术量的影响尚不清楚。本研究旨在调查中国大流行期间髋关节和膝关节置换手术量,并评估其变化趋势。
从国家药品监督管理局(NMPA)注册的供应商处收集 2011 年至 2021 年全膝关节置换术(TKA)、全髋关节置换术(THA)和股骨头置换术(FHR)的假体年销售量。从北京关节学会(BJS)会员医院收集 TKA、THA、FHR、单髁膝关节置换术(UKA)和髋关节/膝关节置换术翻修(RJA)的年手术量。我们使用线性回归估计手术量损失。使用英国和澳大利亚关节登记处的年手术量进行比较。
在中国,2020 年 THA/FHR、TKA 和 UKA 的手术量均低于预测值,分别减少了 82525 例(13.46%)、165178 例(33.50%)和 151 例(0.65%)。所有三种手术在 2021 年均有显著恢复。THA/FHR 和 UKA 的手术量分别比预测水平高出 68813 和 9402 例,而 TKA 手术量仍略低于预测水平。北京的区域统计数据显示出类似的变化模式。2020 年,THA/FHR、TKA、FHR 和 UKA 的手术量均低于预测值,分别减少了 5031 例(43.37%)、5290 例(40.69%)、620 例(29.18%)和 925 例(39.11%)。2021 年,除 FHR 外,这些手术的数量与 2020 年相比有所增加,但仍低于预测值。与英国和澳大利亚的数据相比,中国在 COVID-19 大流行期间接受髋关节和膝关节置换术的老年人(>65 岁)比例下降较少,恢复速度较快。
在 COVID-19 大流行期间,尽管中国髋关节和膝关节置换手术量与其他国家呈现出相似的“恢复-恢复”变化模式,但在这一领域的损失较小。